<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>)/spinocerebellar <z:hpo ids='HP_0001251'>ataxia</z:hpo> type 3 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e>) is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorder</z:e> caused by polyglutamine expansion in the ataxin-3 protein that confers a toxic gain of function </plain></SENT>
<SENT sid="1" pm="."><plain>Because of the <z:hpo ids='HP_0003584'>late onset</z:hpo> of the disease, we hypothesize that the accumulated <z:mp ids='MP_0003674'>oxidative stress</z:mp> or/and defective <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme ability may be contributory factors in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we utilized SK-N-SH and COS7 cells stably transfected with full-length <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> with 78 polyglutamine repeats to examine any alterations in the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> activity </plain></SENT>
<SENT sid="3" pm="."><plain>We demonstrated a significant reduction in the ratio of GSH/GSSG and total <z:chebi fb="0" ids="16856">glutathione</z:chebi> content (GSH + 2x GSSG) in mutant <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> cells compared with the <z:mp ids='MP_0002169'>wild-type</z:mp> cells under <z:mpath ids='MPATH_458'>normal</z:mpath> or stressful conditions </plain></SENT>
<SENT sid="4" pm="."><plain>We also showed that both SK-N-SH-MJD78 and COS7-MJD78-GFP cell lines have lower activities of catalase, <z:chebi fb="0" ids="16856">glutathione</z:chebi> reductase, and <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase compared with the <z:mp ids='MP_0002169'>wild-type</z:mp> cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, it is known that, when cells are under <z:mp ids='MP_0003674'>oxidative stress</z:mp>, the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> DNA is prone to damage </plain></SENT>
<SENT sid="6" pm="."><plain>Our results demonstrated that <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> DNA copy numbers are decreased in mutant cells and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> patients' samples compared with the <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="7" pm="."><plain>Furthermore, the amount of common <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> DNA 4,977-bp deletion is higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> patients compared with that in <z:mpath ids='MPATH_458'>normal</z:mpath> individuals </plain></SENT>
<SENT sid="8" pm="."><plain>Overall, mutant ataxin-3 may influence the activity of enzymatic components to remove <z:chebi fb="0" ids="15379">O(2)</z:chebi>(-) and <z:chebi fb="0" ids="16240">H(2)O(2)</z:chebi> efficiently and promote <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> DNA damage or <z:mpath ids='MPATH_63'>depletion</z:mpath>, which leads to dysfunction of mitochondria </plain></SENT>
<SENT sid="9" pm="."><plain>Therefore, we suggest that the cell damage caused by greater <z:mp ids='MP_0003674'>oxidative stress</z:mp> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SCA3</z:e> mutant cells plays an important role, at least in part, in the disease progression </plain></SENT>
</text></document>